|
|
|
| home > white papers > The Power of Execution in Clinical Research - Medpace |
|
|
 WHITE PAPERS |
|
Medpace
|
|
The Power of Execution in Clinical Research
|
|
Medpace, long known for its excellence in conducting Phase I-IV studies on a global platform, is particularly noted for its therapeutic excellence. When that expertise is combined with operational precision, the results are nothing short of stellar. The Medpace full-service outsourcing approach – combined with therapeutic expertise, regulatory know how, and global presence – delivers clinical studies with an industry recognized track record.
|
|
|
|
|
|
|
 |
News and Press Releases |
 |
Aptar Pharma Completes First Phase of Global Expansion Program to Meet Growing Customer Capacity Needs for Injectable Drug Delivery
Crystal Lake, Illinois, October 31, 2022 - Aptar Pharma, a global
leader in drug delivery systems, services and active material science
solutions, today announced that it has delivered the first phase of its
previously announced expansion program of approximately $180 million USD
to meet growing customer capacity needs for injection system solutions.
The multisite, international expansion project began in 2020 and is
intended to significantly boost capacity across all product lines,
ultimately enabling Aptar Pharma to produce over 10 billion injectable
component units annually when completed.
More info >> |
|
 |
White Papers |
 |
|
How To Increase Efficiency, Customer Satisfaction and Reduce Cost
AC Labels
A customer of Riverside Medical had required a complex four-part 'piggy back' label. The labels needed to be specially constructed to facilitate removal in parts at various stages of its use for quality control traceability. This label needed to carry variable data elements of LOT numbers, batch numbers and product descriptions, and also a secondary gamma indicator label placed on each of its 4 sections to prove its sterility following sterilisation.
More info >> |
|
|
|
